Capecitabine
17-585
Phase 2 small_molecule active
Quick answer
Capecitabine for Breast Cancer is a Phase 2 program (small_molecule) at PUMA BIOTECHNOLOGY, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- PUMA BIOTECHNOLOGY, INC.
- Indication
- Breast Cancer
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active